Safety Study of Outdoor and Indoor Mobility in People With Spinal Cord Injury (ROBOtics Spinal Cord Injury EKSO).

Overview

The aim of this study will be to evaluate the safety and the efficacy of a new robotic exoskeleton device in subjects with Spinal Cord Injury (SCI) and in subjects with other neurological disease with an impairment of lower limbs.

Full Title of Study: “ROBOticsSpinalCordInjuryEKSO: Outdoor and Indoor Mobility in People With SCI.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2015

Detailed Description

In this study, 30 participants with chronic spinal cord injury will undergo a 8-week training schedule for ambulation with the EKSO™ device. Ekso™ is a wearable bionic suit which enables individuals with any amount of lower extremity weakness to stand up and walk over ground with a natural, full weight bearing, reciprocal gait. Walking is achieved by the user's weight shifts to activate sensors in the device which initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. Ekso provides functional based rehabilitation, over ground gait training, and upright, weight bearing exercise unlike any other. It has been designed for the needs of busy therapists treating a wide range of patients in a single day. The suit is strapped over the users´ clothing with easy adjustments to transition between patients in as little as five minutes. Before, during and after training sessions the subjects will perform standardised assessments and complete questionnaires to assess the functional and psychological effects of the exoskeleton.

Interventions

  • Device: EKSO
    • The subjects will undergo inpatient rehabilitation consisting of a treatment cycle of 30/40 training section using the robot EKSO system device, according to individually tailored exercise scheduling. The practice will include robot-assisted walking at variable speeds for 45/60 min and balance training.

Arms, Groups and Cohorts

  • Experimental: Robot Safety and Efficacy
    • The subjects will undergo inpatient rehabilitation consisting of a treatment cycle of 30/40 training section using the robot EKSO system device, according to individually tailored exercise scheduling. The practice will include robot-assisted walking at variable speeds for 45/60 min and balance training.

Clinical Trial Outcome Measures

Primary Measures

  • Change from Baseline in Gait Spatiotemporal and Kinematic parameters at 6 months.
    • Time Frame: Ekso training at 0 and 8 weeks, and 24-week follow-up.
    • Change in score between 0 and 24 weeks. 3D Gait Analysis will be collected at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).

Secondary Measures

  • Participant Satisfaction Questionnaire.
    • Time Frame: Ekso training at 0 and 8 weeks, and 24-week follow-up
    • Change in score between 0 and 24 weeks. The 10 questions will be asked for each subject during and upon the completion of the active participation phase of the treatment.
  • Change in blood pressure and heart rate during the training.
    • Time Frame: Ekso training at 0 and 8 weeks, and 24-week follow-up.
    • Blood pressure and heart rate will be monitorized every day during the training and the data will be collected at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).
  • 6 minutes walking test.
    • Time Frame: Ekso training at 0 and 8 weeks, and 24-week follow-up.
    • Change in score between 0 and 24 weeks. The 6 minutes walking test will be collected in indoor and outdoor condition at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).
  • Timed Up and Go test.
    • Time Frame: Ekso training at 0 and 8 weeks, and 24-week follow-up.
    • Change in score between 0 and 24 weeks. Timed Up and Go test will be collected in indoor and outdoor condition at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).

Participating in This Clinical Trial

Inclusion Criteria

  • Chronic motor complete or incomplete cervical and thoracic (C7-T12) spinal cord injury. – Skin integrity. – Adequate hip, knee and ankle range of motion. – Spasticity level of 3 or less (Ashworth scale). Exclusion Criteria:

  • Cardiological or respiratory comorbidity. – Hemodynamic instability. – Presence of unhealed fractures. – Presence of heterotopic ossification that may impede walking. – Presence of osteoporosis.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • IRCCS San Raffaele Roma
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Patrizio Sale, MD, Principal Investigator, IRCCS San Raffaele Pisana Roma

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.